Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 3 , Pages 129-133, May 2008

Type 3 Phosphodiesterase Inhibitors May Be Protective Against Cerebrovascular Events in Patients with Claudication

  • William M. Stone, MD

      Affiliations

    • Division of Vascular Surgery, Mayo Clinic College of Medicine. Mayo Clinic Arizona, Phoenix, Arizona
    • Corresponding Author InformationAddress correspondence to William M. Stone, MD, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ 85054.
  • ,
  • Bart M. Demaerschalk, MD, MSc, FRCP(C)

      Affiliations

    • Department of Neurology, Mayo Clinic College of Medicine. Mayo Clinic Arizona, Phoenix, Arizona
  • ,
  • Richard J. Fowl, MD

      Affiliations

    • Division of Vascular Surgery, Mayo Clinic College of Medicine. Mayo Clinic Arizona, Phoenix, Arizona
  • ,
  • Samuel R. Money, MD, MBA

      Affiliations

    • Division of Vascular Surgery, Mayo Clinic College of Medicine. Mayo Clinic Arizona, Phoenix, Arizona

Received 13 August 2007; received in revised form 8 December 2007; accepted 19 December 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1052-3057(08)00010-4

doi:10.1016/j.jstrokecerebrovasdis.2007.12.005

Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 3 , Pages 129-133, May 2008